Clinical Trial Update: An Open Label, Pilot Investigation, to Assess the Safety and Efficacy of Transplantation of Macro-encapsulated Human Islets Within the Bioartificial Pancreas Beta-Air in Patients With Type 1 Diabetes Mellitus [Phase 1, Phase 2]

View source ↗

Summary

An open-label Phase 1/2 pilot study evaluating the safety and efficacy of transplanting macro-encapsulated human islets within the Bioartificial Pancreas Beta-A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Uppsala University Hospital | Conditions: Long-standing Type 1 Diabetes Mellitus | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING